These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6464658)
1. Effect of interferon on antibody-dependent cellular cytotoxicity (ADCC) in chickens. Mándi Y; Bakay M; Béládi I Acta Microbiol Hung; 1984; 31(2):127-33. PubMed ID: 6464658 [TBL] [Abstract][Full Text] [Related]
2. The effect of interferon on ADCC (I). Spangsbjerg N; Heron I Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):315-21. PubMed ID: 6659937 [TBL] [Abstract][Full Text] [Related]
3. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients. Koren HS; Brandt CP; Tso CY; Laszlo J J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332 [TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor. Fuson EW; Cole AJ; Hubbard RA J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410 [TBL] [Abstract][Full Text] [Related]
5. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864 [TBL] [Abstract][Full Text] [Related]
6. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells. Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412 [TBL] [Abstract][Full Text] [Related]
7. Interferon enhances the antibody-dependent cellular cytotoxicity (ADCC) of human polymorphonuclear leukocytes. Hokland P; Berg K J Immunol; 1981 Oct; 127(4):1585-8. PubMed ID: 6168696 [TBL] [Abstract][Full Text] [Related]
8. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2. Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf I Cytokine; 2000 Jun; 12(6):756-61. PubMed ID: 10843759 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of surface FcRI and decrease in antibody-dependent cellular cytotoxicity of cultured monocytes. Reversal by monensin or cytochalasin-D. Tripathi AK; Taplits M; Puri J; Hoffman T J Immunol; 1991 Feb; 146(4):1309-15. PubMed ID: 1991969 [TBL] [Abstract][Full Text] [Related]
10. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon. Munn DH; Armstrong E Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423 [TBL] [Abstract][Full Text] [Related]
11. Lysis of antibody coated chicken erythrocytes by a non-lymphocyte pig blood leukocyte. Charley B; Salmon H Ann Rech Vet; 1980; 11(1):13-20. PubMed ID: 7436327 [TBL] [Abstract][Full Text] [Related]
12. Immune-enhancing effect of recombinant human interferon-beta produced in Escherichia coli on human peripheral blood mononuclear cells in vitro. Okabe M; Morimoto M; Nakamizo N Gan; 1983 Oct; 74(5):743-50. PubMed ID: 6357933 [TBL] [Abstract][Full Text] [Related]
13. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis. Hall RE; Muchmore AV; Blaese RM J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988 [TBL] [Abstract][Full Text] [Related]
14. Regulation of natural and antibody-dependent cellular cytotoxicity by staphylococcal enterotoxin A. Kimber I; Bakács T; Moore M Clin Exp Immunol; 1983 Oct; 54(1):39-48. PubMed ID: 6616973 [TBL] [Abstract][Full Text] [Related]
15. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients. Köhler E; Knospe S; Hahn HJ; Roemer KG; Diamantstein T Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of human mononuclear cells against chicken and human red blood cells, induced by treatment of the effector cells with phospholipase C. Northoff H; Resch K Eur J Immunol; 1979 Oct; 9(10):757-61. PubMed ID: 520407 [TBL] [Abstract][Full Text] [Related]
17. Effect of Fiblaferon-L on the human immune system. Zafra C; de la Fuente M; Gaytan F; Solana R; Peña J Chemotherapy; 1984; 30(2):131-6. PubMed ID: 6365481 [TBL] [Abstract][Full Text] [Related]
18. Hemolysis due to human antibody-dependent cell-mediated cytotoxicity. Lysis of erythrocytes treated with anti-D serum. Yust I; Goldsher N; Greenfeld R; Rabinovitz M Isr J Med Sci; 1980 Mar; 16(3):174-80. PubMed ID: 6771228 [TBL] [Abstract][Full Text] [Related]
19. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of the functional activities of human T cells after their interaction with SRBC. Silva A; Lopez-Botet M; Alvarez J; de Landazuri MO J Immunol; 1981 Feb; 126(2):393-7. PubMed ID: 6450242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]